Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi J A Wallweber

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Molecular Biology|September 29, 2004
The crystal structure of a proliferation-inducing ligand, APRILHeidi J A Wallweber, Deanne M Compaan, Melissa A Starovasnik, et al.
Nature Structural & Molecular Biology|April 8, 2014
Structural basis of recognition of interferon-α receptor by tyrosine kinase 2Heidi J A Wallweber, Christine Tam, Yvonne Franke, et al.
Structure (London, England : 1993)|May 3, 2016
The Structural Basis for Class II Cytokine Receptor Recognition by JAK1Ryan Ferrao, Heidi J A Wallweber, Hoangdung Ho, et al.
Structure (London, England : 1993)|December 6, 2003
The crystal structures of EDA-A1 and EDA-A2: splice variants with distinct receptor specificitySarah G Hymowitz, Deanne M Compaan, Minhong Yan, et al.
The Journal of Biological Chemistry|February 7, 2004
Engineering an APRIL-specific B cell maturation antigenDarshana R Patel, Heidi J A Wallweber, JianPing Yin, et al.
Journal of Molecular Biology|December 1, 2009
Multiple novel classes of APRIL-specific receptor-blocking peptides isolated by phage displayNathaniel C Gordon, Samantha Lien, Jeremy Johnson, et al.
The Biochemical Journal|October 16, 2004
Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAPDomagoj Vucic, Matthew C Franklin, Heidi J A Wallweber, et al.
ACS Chemical Biology|December 16, 2006
Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPsKerry Zobel, Lan Wang, Eugene Varfolomeev, et al.
Neuropharmacology|May 2, 2017
A novel NMDA receptor positive allosteric modulator that acts via the transmembrane domainTzu-Ming Wang, Brandon M Brown, Lunbin Deng, et al.
The Journal of Biological Chemistry|November 16, 2004
Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand bindingSarah G Hymowitz, Darshana R Patel, Heidi J A Wallweber, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Molecular Biology|September 29, 2004
The crystal structure of a proliferation-inducing ligand, APRILHeidi J A Wallweber, Deanne M Compaan, Melissa A Starovasnik, et al.
Nature Structural & Molecular Biology|April 8, 2014
Structural basis of recognition of interferon-α receptor by tyrosine kinase 2Heidi J A Wallweber, Christine Tam, Yvonne Franke, et al.
Structure (London, England : 1993)|May 3, 2016
The Structural Basis for Class II Cytokine Receptor Recognition by JAK1Ryan Ferrao, Heidi J A Wallweber, Hoangdung Ho, et al.
Structure (London, England : 1993)|December 6, 2003
The crystal structures of EDA-A1 and EDA-A2: splice variants with distinct receptor specificitySarah G Hymowitz, Deanne M Compaan, Minhong Yan, et al.
The Journal of Biological Chemistry|February 7, 2004
Engineering an APRIL-specific B cell maturation antigenDarshana R Patel, Heidi J A Wallweber, JianPing Yin, et al.
Journal of Molecular Biology|December 1, 2009
Multiple novel classes of APRIL-specific receptor-blocking peptides isolated by phage displayNathaniel C Gordon, Samantha Lien, Jeremy Johnson, et al.
The Biochemical Journal|October 16, 2004
Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAPDomagoj Vucic, Matthew C Franklin, Heidi J A Wallweber, et al.
ACS Chemical Biology|December 16, 2006
Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPsKerry Zobel, Lan Wang, Eugene Varfolomeev, et al.
Neuropharmacology|May 2, 2017
A novel NMDA receptor positive allosteric modulator that acts via the transmembrane domainTzu-Ming Wang, Brandon M Brown, Lunbin Deng, et al.
The Journal of Biological Chemistry|November 16, 2004
Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand bindingSarah G Hymowitz, Darshana R Patel, Heidi J A Wallweber, et al.
Pageof 2